PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $267,000 | +66.9% | 59,480 | +81.0% | 0.02% | +23.1% |
Q3 2021 | $160,000 | -17.1% | 32,867 | +6.8% | 0.01% | -35.0% |
Q4 2020 | $193,000 | -22.2% | 30,781 | +26.5% | 0.02% | +17.6% |
Q2 2018 | $248,000 | -53.1% | 24,336 | -40.2% | 0.02% | -54.1% |
Q1 2018 | $529,000 | – | 40,703 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |